IMBRUVICA 70 MG/ML SUS OR CT FR VD AMB X 112 ML + 2 SER DOS
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1123634450019 -
GGREM
514524110040905 -
Código de barras
7896212485451
O que a fonte publica
- Detentor do registro
- JANSSEN-CILAG FARMACEUTICA LTDA
- Princípios ativos
- IBRUTINIBE
- Embalagem
- 70 MG/ML SUS OR CT FR VD AMB X 112 ML + 2 SER DOS
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- L1H6 - ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA QUINASE, BTK
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "IMBRUVICA 70 MG/ML SUS OR CT FR VD AMB X 112 ML + 2 SER DOS",
"holder": "JANSSEN-CILAG FARMACEUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896212485451"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "514524110040905",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "51.780.468/0001-87",
"priceRegime": "Regulado",
"productName": "IMBRUVICA",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "70 MG/ML SUS OR CT FR VD AMB X 112 ML + 2 SER DOS",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "27100.63",
"icms-12": "30796.18",
"icms-17": "32651.35",
"icms-18": "33049.54",
"icms-19": "33457.57",
"icms-20": "33875.79",
"icms-21": "34304.60",
"icms-22": "34744.39",
"icms-23": "35195.62",
"icms-17.5": "32849.24",
"icms-19.5": "33665.38",
"icms-20.5": "34088.85",
"icms-22.5": "34968.57",
"icms-12-alc": "27496.60",
"icms-17-alc": "29152.99",
"icms-18-alc": "29508.52",
"icms-19-alc": "29872.81",
"icms-20-alc": "30246.23",
"icms-21-alc": "30629.10",
"icms-22-alc": "31021.77",
"icms-23-alc": "31424.64",
"withoutTaxes": "24196.99",
"icms-17.5-alc": "29329.68",
"icms-19.5-alc": "30058.37",
"icms-20.5-alc": "30436.45",
"icms-22.5-alc": "31221.90"
},
"pisCofinsList": "Negativa",
"substanceText": "IBRUTINIBE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "36354.53",
"icms-12": "41311.98",
"icms-17": "43800.62",
"icms-18": "44334.78",
"icms-19": "44882.14",
"icms-20": "45443.17",
"icms-21": "46018.40",
"icms-22": "46608.36",
"icms-23": "47213.67",
"icms-17.5": "44066.09",
"icms-19.5": "45160.91",
"icms-20.5": "45728.98",
"icms-22.5": "46909.09",
"icms-12-alc": "38012.44",
"icms-17-alc": "40302.30",
"icms-18-alc": "40793.80",
"icms-19-alc": "41297.41",
"icms-20-alc": "41813.64",
"icms-21-alc": "42342.93",
"icms-22-alc": "42885.78",
"icms-23-alc": "43442.72",
"withoutTaxes": "33450.92",
"icms-17.5-alc": "40546.56",
"icms-19.5-alc": "41553.93",
"icms-20.5-alc": "42076.61",
"icms-22.5-alc": "43162.45"
},
"invalidBarcodes": [],
"activeSubstances": [
"IBRUTINIBE"
],
"therapeuticClass": "L1H6 - ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA QUINASE, BTK",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1123634450019",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1H6",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:514524110040905"